Health Products

Kenalog-40 Injection (2014-03-04)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
3J74513A. Kenalog-40 Injection
Recalling Firm
CanadaDrugs.com LP
10 Terracon Place
Winnipeg
R2J 4G7
Manitoba
CANADA
Marketing Authorization Holder
Bristol-Myers Squibb Canada
2344 Boul. Alfred-Nobel, Suite 300
Montréal (Saint-Laurent)
H4S 0A4
Quebec
CANADA
SuspensionDIN 01999869Triamcinolone Acetonide, 40 mg/mL

Introduction

Recalled products
  1. Kenalog-40 Injection

Reason

This product may have been exposed to temperatures outside of the recommended storage requirements during their transport from CanadaDrugs.com to Canada Diagnostic Centres in Alberta, Canada. The safety and efficacy of these drugs may be impacted by the temperature excursion.

Note: only the units shipped from CanadaDrugs.com to Canada Diagnostics Centres in Alberta, Canada are affected, not the entire lots.

Depth of distribution

Distributed to Canada Diagnostic Centres in Alberta, Canada.

Note: all other units of these lots of Kenalog 40 mg/mL sold by Bristol-Myers Squibb Canada are not impacted by this recall.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime